Loading clinical trials...
Loading clinical trials...
The main research question of this study is to obtain further safety and effectiveness data on Pradaxa Pellets in children aged 3 months to less than 12 years in routine clinical practice setting.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Boehringer Ingelheim
Collaborators
NCT05735639 · Venous Thromboembolism, Varicose Veins
NCT06189313 · Pulmonary Embolism, Acute Pulmonary Embolism, and more
NCT07015905 · Venous Thromboembolism (VTE)
NCT03728166 · Venous Thromboembolism
NCT07140211 · Venous Thromboembolism (VTE), Postpartum
University of California, San Diego
La Jolla, California
Rady Children's Hospital
San Diego, California
Yale University School of Medicine
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions